CJC 1295 + DAC

What is CJC-1295 DAC

CJC-1295 with DAC is referred to the peptides class, stimulating the body’s own production of growth hormone, which, unlike its counterpart CJC-1295 (GRF 1-29), has a much longer half-life in the blood, lasting up to two weeks. In concordance with a number of laboratory studies, the peptide allows binding CJC-1295 DAC albumin, plasma proteins, which is leading to an increased effect, largely due to the impact of lysine bound with Drug Affinity Complex (DAC). A modified CJC 1295 (GRF 1-29) offers a 30 minutes half-life while DAC CJC-1295 builds a 6-8 days effect, which is ideal for 2 times per week injections. Clinical trials demonstrated a considerable increase of growth hormone plasma levels in 2-10 times with a duration of 6 days, as well as IGF-1 concentration increase in 1.5-3 times with an impressive duration of 9-11 days after the initial injection. By efficiency the preparation is equal to the cycle of growth hormone of 15 IU/day, boasting a truly democratic price.

CJC-1295 DAC Results

Scientific researchers confirm that the properties of CJC-1295 DAC offer a similar growth hormone impact:

• The peptide provides a dramatic increase in
the strength and endurance;
• A tangible and progressive muscle growth
is achieved;
• Body fat level is decreased, particularly in
the abdominal cavity;
• The modified product affects the quality of
the skin in a positive way, smoothes
wrinkles and provides elasticity;
• The peptide increases the density of the
bone structure of the human body;
• A noteworthy ligaments and joints
strengthening is achieved; more rapid
recovery after injuries and intense
exercises takes place;
• A correct dosage provides a favourable
effect on sleep and overall mental state.

CJC-1295 DAC dosage

To maintain optimum concentration it is necessary to carry out injections 2 times per week (since by the fifth day it falls to ineffective). The recommended dosage equals 1000-2000mcg, 2 times a week. The optimal cjc-1295 dac cycle duration is 8-12 weeks, followed by a 2-week break. To prevent age-related changes (40+), only one injection of 1 time per week (at bedtime). It is advisable to combine this peptide with GHRP-2, GHRP-6 or Ipamorelin so the to triple the result and achieve a synergistic effect.